<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35567617</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2366-0058</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>14</Day>
            </PubDate>
          </JournalIssue>
          <Title>Abdominal radiology (New York)</Title>
          <ISOAbbreviation>Abdom Radiol (NY)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>MR elastography in primary sclerosing cholangitis: a pictorial review.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00261-022-03529-x</ELocationID>
        <Abstract>
          <AbstractText>Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by biliary ductal inflammation and fibrosis causing both intrahepatic and extrahepatic biliary strictures and dilatation. There is currently no effective medical treatment and the disease leads to cirrhosis and liver failure, with patients often requiring liver transplantation in end-stage disease. Liver fibrosis is one of the most important factors in determining patient outcome in PSC, and the diagnosis and monitoring of fibrosis are vital to patient care. MRI with magnetic resonance cholangiopancreatography is the non-invasive imaging modality of choice in PSC and is useful for the evaluation of parenchymal and biliary changes. Biliary ductal abnormalities, however, cannot always predict the presence of liver fibrosis and alternative means are needed. MR Elastography (MRE) is the most accurate non-invasive method for assessing liver fibrosis and is particularly helpful in PSC due to unique hepatic manifestations. Like other non-invasive modalities, MRE measures liver stiffness as an indirect method for assessing fibrosis. Given the ability of MRE to assess liver fibrosis and the importance of fibrosis in PSC patients, MRE can reliably predict patient outcome. In this pictorial review, we will review MR findings of PSC, with an emphasis on MRE, and demonstrate scenarios where MRE is particularly helpful in evaluating PSC patients.</AbstractText>
          <CopyrightInformation>Â© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Welle</LastName>
            <ForeName>Christopher L</ForeName>
            <Initials>CL</Initials>
            <Identifier Source="ORCID">0000-0001-7864-9190</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Mayo Clinic, Rochester, MN, USA. Welle.Christopher@mayo.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Navin</LastName>
            <ForeName>Patrick J</ForeName>
            <Initials>PJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Mayo Clinic, Rochester, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Olson</LastName>
            <ForeName>Michael C</ForeName>
            <Initials>MC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Mayo Clinic, Rochester, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hoodeshenas</LastName>
            <ForeName>Safa</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Mayo Clinic, Rochester, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Torbenson</LastName>
            <ForeName>Michael S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Mayo Clinic, Rochester, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Venkatesh</LastName>
            <ForeName>Sudhakar K</ForeName>
            <Initials>SK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Mayo Clinic, Rochester, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Abdom Radiol (NY)</MedlineTA>
        <NlmUniqueID>101674571</NlmUniqueID>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Hepatic fibrosis</Keyword>
        <Keyword MajorTopicYN="N">Liver stiffness</Keyword>
        <Keyword MajorTopicYN="N">MR elastography</Keyword>
        <Keyword MajorTopicYN="N">Macroregenerative nodule</Keyword>
        <Keyword MajorTopicYN="N">Primary sclerosing cholangitis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>14</Day>
          <Hour>11</Hour>
          <Minute>13</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35567617</ArticleId>
        <ArticleId IdType="doi">10.1007/s00261-022-03529-x</ArticleId>
        <ArticleId IdType="pii">10.1007/s00261-022-03529-x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Razumilava N, Gores GJ, Lindor KD (2011) Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 54 (5):1842-1852. doi: https://doi.org/10.1002/hep.24570</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.24570</ArticleId>
            <ArticleId IdType="pubmed">21793028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, Sandberg-Gertzen H, Wallerstedt S, Lindberg G (1996) Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38 (4):610-615. doi: https://doi.org/10.1136/gut.38.4.610</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.38.4.610</ArticleId>
            <ArticleId IdType="pubmed">8707097</ArticleId>
            <ArticleId IdType="pmc">1383124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corpechot C, Gaouar F, El Naggar A, Kemgang A, Wendum D, Poupon R, Carrat F, Chazouilleres O (2014) Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Gastroenterology 146 (4):970-979; quiz e915-976. doi: https://doi.org/10.1053/j.gastro.2013.12.030</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2013.12.030</ArticleId>
            <ArticleId IdType="pubmed">24389304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Vries EM, Verheij J, Hubscher SG, Leeflang MM, Boonstra K, Beuers U, Ponsioen CY (2015) Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis. J Hepatol 63 (5):1212-1219. doi: https://doi.org/10.1016/j.jhep.2015.06.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2015.06.008</ArticleId>
            <ArticleId IdType="pubmed">26095184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schramm C, Eaton J, Ringe KI, Venkatesh S, Yamamura J, IPSCSG MRIwgot (2017) Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group. Hepatology 66 (5):1675-1688. doi: https://doi.org/10.1002/hep.29293</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.29293</ArticleId>
            <ArticleId IdType="pubmed">28555945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zenouzi R, Welle CL, Venkatesh SK, Schramm C, Eaton JE (2019) Magnetic Resonance Imaging in Primary Sclerosing Cholangitis-Current State and Future Directions. Semin Liver Dis 39 (3):369-380. doi: https://doi.org/10.1055/s-0039-1687853</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0039-1687853</ArticleId>
            <ArticleId IdType="pubmed">31041791</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Srinivasa Babu A, Wells ML, Teytelboym OM, Mackey JE, Miller FH, Yeh BM, Ehman RL, Venkatesh SK (2016) Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions. Radiographics 36 (7):1987-2006. doi: https://doi.org/10.1148/rg.2016160042</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/rg.2016160042</ArticleId>
            <ArticleId IdType="pubmed">27689833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venkatesh SK, Yin M, Ehman RL (2013) Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging 37 (3):544-555. doi: https://doi.org/10.1002/jmri.23731</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jmri.23731</ArticleId>
            <ArticleId IdType="pubmed">23423795</ArticleId>
            <ArticleId IdType="pmc">3579218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eaton JE, Dzyubak B, Venkatesh SK, Smyrk TC, Gores GJ, Ehman RL, LaRusso NF, Gossard AA, Lazaridis KN (2016) Performance of magnetic resonance elastography in primary sclerosing cholangitis. J Gastroenterol Hepatol 31 (6):1184-1190. doi: https://doi.org/10.1111/jgh.13263</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jgh.13263</ArticleId>
            <ArticleId IdType="pubmed">26691631</ArticleId>
            <ArticleId IdType="pmc">4885758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eaton JE, Talwalkar JA, Lazaridis KN, Gores GJ, Lindor KD (2013) Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology 145 (3):521-536. doi: https://doi.org/10.1053/j.gastro.2013.06.052</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2013.06.052</ArticleId>
            <ArticleId IdType="pubmed">23827861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bookwalter CA, Venkatesh SK, Eaton JE, Smyrk TD, Ehman RL (2018) MR elastography in primary sclerosing cholangitis: correlating liver stiffness with bile duct strictures and parenchymal changes. Abdom Radiol (NY) 43 (12):3260-3270. doi: https://doi.org/10.1007/s00261-018-1590-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00261-018-1590-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jhaveri KS, Hosseini-Nik H, Sadoughi N, Janssen H, Feld JJ, Fischer S, Menezes R, Cheung AC (2019) The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitis. Eur Radiol 29 (2):1039-1047. doi: https://doi.org/10.1007/s00330-018-5619-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00330-018-5619-4</ArticleId>
            <ArticleId IdType="pubmed">30051141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eaton JE, Sen A, Hoodeshenas S, Schleck CD, Harmsen WS, Gores GJ, LaRusso NF, Gossard AA, Lazaridis KN, Venkatesh SK (2020) Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol 18 (7):1576-1583 e1571. doi: https://doi.org/10.1016/j.cgh.2019.10.041</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cgh.2019.10.041</ArticleId>
            <ArticleId IdType="pubmed">31683058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venkatesh SK, Welle CL, Miller FH, Jhaveri K, Ringe KI, Eaton JE, Bungay H, Arrive L, Ba-Ssalamah A, Grigoriadis A, Schramm C, Fulcher AS, Ipscsg (2022) Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Eur Radiol 32 (2):923-937. doi: https://doi.org/10.1007/s00330-021-08147-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00330-021-08147-7</ArticleId>
            <ArticleId IdType="pubmed">34363134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pepin KM, Chen J, Glaser KJ, Mariappan YK, Reuland B, Ziesmer S, Carter R, Ansell SM, Ehman RL, McGee KP (2014) MR elastography derived shear stiffness--a new imaging biomarker for the assessment of early tumor response to chemotherapy. Magn Reson Med 71 (5):1834-1840. doi: https://doi.org/10.1002/mrm.24825</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mrm.24825</ArticleId>
            <ArticleId IdType="pubmed">23801372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khoshpouri P, Habibabadi RR, Hazhirkarzar B, Ameli S, Ghadimi M, Ghasabeh MA, Menias CO, Kim A, Li Z, Kamel IR (2019) Imaging Features of Primary Sclerosing Cholangitis: From Diagnosis to Liver Transplant Follow-up. Radiographics 39 (7):1938-1964. doi: https://doi.org/10.1148/rg.2019180213</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/rg.2019180213</ArticleId>
            <ArticleId IdType="pubmed">31626561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz A, Lemoinne S, Carrat F, Corpechot C, Chazouilleres O, Arrive L (2014) Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology 59 (1):242-250. doi: https://doi.org/10.1002/hep.26620</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26620</ArticleId>
            <ArticleId IdType="pubmed">23857427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ito K, Mitchell DG, Outwater EK, Blasbalg R (1999) Primary sclerosing cholangitis: MR imaging features. AJR Am J Roentgenol 172 (6):1527-1533. doi: https://doi.org/10.2214/ajr.172.6.10350284</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/ajr.172.6.10350284</ArticleId>
            <ArticleId IdType="pubmed">10350284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kovac JD, Jesic R, Stanisavljevic D, Kovac B, Maksimovic R (2013) MR imaging of primary sclerosing cholangitis: additional value of diffusion-weighted imaging and ADC measurement. Acta Radiol 54 (3):242-248. doi: https://doi.org/10.1177/0284185112471792</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0284185112471792</ArticleId>
            <ArticleId IdType="pubmed">23386736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bader TR, Beavers KL, Semelka RC (2003) MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology 226 (3):675-685. doi: https://doi.org/10.1148/radiol.2263011623</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiol.2263011623</ArticleId>
            <ArticleId IdType="pubmed">12616016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reiter R, Shahryari M, Tzschatzsch H, Klatt D, Siegmund B, Hamm B, Braun J, Sack I, Asbach P (2021) Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis vs. viral hepatitis assessed by MR elastography. Sci Rep 11 (1):9820. doi: https://doi.org/10.1038/s41598-021-89372-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-021-89372-4</ArticleId>
            <ArticleId IdType="pubmed">33972639</ArticleId>
            <ArticleId IdType="pmc">8110576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Idilman IS, Li J, Yin M, Venkatesh SK (2020) MR elastography of liver: current status and future perspectives. Abdom Radiol (NY) 45 (11):3444-3462. doi: https://doi.org/10.1007/s00261-020-02656-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00261-020-02656-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts P, Trout AT, Dillman JR (2018) Nodular macroregenerative tissue as a pattern of regeneration in cholangiopathic disorders. Pediatr Radiol 48 (7):932-940. doi: https://doi.org/10.1007/s00247-018-4129-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00247-018-4129-5</ArticleId>
            <ArticleId IdType="pubmed">29675756</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dillman JR, Serai SD, Trout AT, Singh R, Tkach JA, Taylor AE, Blaxall BC, Fei L, Miethke AG (2019) Diagnostic performance of quantitative magnetic resonance imaging biomarkers for predicting portal hypertension in children and young adults with autoimmune liver disease. Pediatr Radiol 49 (3):332-341. doi: https://doi.org/10.1007/s00247-018-4319-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00247-018-4319-1</ArticleId>
            <ArticleId IdType="pubmed">30607435</ArticleId>
            <ArticleId IdType="pmc">8530173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wells ML, Fenstad ER, Poterucha JT, Hough DM, Young PM, Araoz PA, Ehman RL, Venkatesh SK (2016) Imaging Findings of Congestive Hepatopathy. Radiographics 36 (4):1024-1037. doi: https://doi.org/10.1148/rg.2016150207</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/rg.2016150207</ArticleId>
            <ArticleId IdType="pubmed">27284758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kozaka K, Sheedy SP, Eaton JE, Venkatesh SK, Heiken JP (2020) Magnetic resonance imaging features of small-duct primary sclerosing cholangitis. Abdom Radiol (NY) 45 (8):2388-2399. doi: https://doi.org/10.1007/s00261-020-02572-w</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00261-020-02572-w</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim HJ, Kim B, Yu HJ, Huh J, Lee JH, Lee SS, Kim KW, Kim JK (2020) Reproducibility of hepatic MR elastography across field strengths, pulse sequences, scan intervals, and readers. Abdom Radiol (NY) 45 (1):107-115. doi: https://doi.org/10.1007/s00261-019-02312-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00261-019-02312-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eaton JE, Talwalkar JA (2013) Primary Sclerosing Cholangitis: Current and Future Management Strategies. Curr Hepat Rep 12 (1):28-36. doi: https://doi.org/10.1007/s11901-012-0155-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11901-012-0155-1</ArticleId>
            <ArticleId IdType="pubmed">23682242</ArticleId>
            <ArticleId IdType="pmc">3652489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fosby B, Karlsen TH, Melum E (2012) Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol 18 (1):1-15. doi: https://doi.org/10.3748/wjg.v18.i1.1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v18.i1.1</ArticleId>
            <ArticleId IdType="pubmed">22228965</ArticleId>
            <ArticleId IdType="pmc">3251800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venkatesh SK, Yin M, Glockner JF, Takahashi N, Araoz PA, Talwalkar JA, Ehman RL (2008) MR elastography of liver tumors: preliminary results. AJR American journal of roentgenology 190 (6):1534-1540. doi: https://doi.org/10.2214/AJR.07.3123</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/AJR.07.3123</ArticleId>
            <ArticleId IdType="pubmed">18492904</ArticleId>
            <ArticleId IdType="pmc">2894569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin M, Glaser KJ, Manduca A, Mounajjed T, Malhi H, Simonetto DA, Wang R, Yang L, Mao SA, Glorioso JM, Elgilani FM, Ward CJ, Harris PC, Nyberg SL, Shah VH, Ehman RL (2017) Distinguishing between Hepatic Inflammation and Fibrosis with MR Elastography. Radiology 284 (3):694-705. doi: https://doi.org/10.1148/radiol.2017160622</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiol.2017160622</ArticleId>
            <ArticleId IdType="pubmed">28128707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li J, Venkatesh SK, Yin M (2020) Advances in Magnetic Resonance Elastography of Liver. Magn Reson Imaging Clin N Am 28 (3):331-340. doi: https://doi.org/10.1016/j.mric.2020.03.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mric.2020.03.001</ArticleId>
            <ArticleId IdType="pubmed">32624152</ArticleId>
            <ArticleId IdType="pmc">7338597</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
